NorthWest Biotherapeutics Inc (NWBO)

[iwasadiver]

You’re overthinking this. Clinical trials are constantly reporting results in the face of new technologies that appear to have significant impact on survival. But until that other entity is reporting P3 data they’re not a threat or a factor. NWBO has data that is way beyond the P3 trial they just did, and it will be the basis of everything they do strategically going forward. it’s that attitude and foresight that will, in my opinion, make this a $100-200 stock in as little as 2 years.

Any astute investor who’s retail has seen and captured this. The big Funds know it also and are simply waiting for the signal they need to start buying in earnest. TLD will unleash the flood of money on the sidelines who know what’s coming. They have the money in the account, just waiting to hit the button. It’s a foregone conclusion in the business.